FI881713A - Menetelmä urokinaasityyppisen plasminogeenin aktivaattorin tuottamiseksi - Google Patents

Menetelmä urokinaasityyppisen plasminogeenin aktivaattorin tuottamiseksi Download PDF

Info

Publication number
FI881713A
FI881713A FI881713A FI881713A FI881713A FI 881713 A FI881713 A FI 881713A FI 881713 A FI881713 A FI 881713A FI 881713 A FI881713 A FI 881713A FI 881713 A FI881713 A FI 881713A
Authority
FI
Finland
Prior art keywords
plasminogen activator
urokinase
producing
type plasminogen
human plasminogen
Prior art date
Application number
FI881713A
Other languages
English (en)
Swedish (sv)
Other versions
FI98219C (fi
FI881713A0 (fi
FI98219B (fi
Inventor
Bernd Meyhack
Jutta Heim
Rolf Buergi
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878709081A external-priority patent/GB8709081D0/en
Priority claimed from IE329987A external-priority patent/IE81116B1/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of FI881713A0 publication Critical patent/FI881713A0/fi
Publication of FI881713A publication Critical patent/FI881713A/fi
Application granted granted Critical
Publication of FI98219B publication Critical patent/FI98219B/fi
Publication of FI98219C publication Critical patent/FI98219C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI881713A 1987-04-15 1988-04-13 Menetelmä urokinaasityyppisen plasminogeenin aktivaattorin tuottamiseksi FI98219C (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB8709081 1987-04-15
GB878709081A GB8709081D0 (en) 1987-04-15 1987-04-15 Production of proteins
GB878714059A GB8714059D0 (en) 1987-04-15 1987-06-16 Production of proteins
GB8714059 1987-06-16
IE329987A IE81116B1 (en) 1986-12-05 1987-12-04 Hybrid plasminogen activators
IE329987 1987-12-04

Publications (4)

Publication Number Publication Date
FI881713A0 FI881713A0 (fi) 1988-04-13
FI881713A true FI881713A (fi) 1988-10-16
FI98219B FI98219B (fi) 1997-01-31
FI98219C FI98219C (fi) 1997-05-12

Family

ID=27263391

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881713A FI98219C (fi) 1987-04-15 1988-04-13 Menetelmä urokinaasityyppisen plasminogeenin aktivaattorin tuottamiseksi

Country Status (18)

Country Link
US (1) US5175105A (fi)
EP (1) EP0288435B1 (fi)
JP (1) JP2894696B2 (fi)
AT (1) ATE102994T1 (fi)
AU (1) AU604305B2 (fi)
CA (1) CA1341306C (fi)
DD (1) DD274053A5 (fi)
DE (1) DE3888386T2 (fi)
DK (1) DK203588A (fi)
ES (1) ES2061719T3 (fi)
FI (1) FI98219C (fi)
HU (1) HU204557B (fi)
IL (1) IL86058A (fi)
MX (1) MX168507B (fi)
MY (1) MY103358A (fi)
NO (1) NO179046C (fi)
NZ (1) NZ224243A (fi)
PT (1) PT87230B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2634495B1 (fr) * 1988-07-01 1990-10-26 Chambon Pierre Procede de preparation d'une proteine par des levures utilisant un systeme inductible, vecteurs et souches transformees correspondantes
DE69034013T2 (de) * 1989-03-06 2003-07-31 Univ Texas Serpin-resistenter T-PA; Mutanten; Gene
US5866413A (en) * 1989-03-06 1999-02-02 Board Of Regents Of The University Of Texas System Pai-1 mutants
EP0387380A1 (en) * 1989-03-17 1990-09-19 BEHRINGWERKE Aktiengesellschaft Mutants of urinary plasminogen activator, their production and use
US5268273A (en) * 1990-12-14 1993-12-07 Phillips Petroleum Company Pichia pastoris acid phosphatase gene, gene regions, signal sequence and expression vectors comprising same
GB2256197B (en) * 1991-05-31 1995-11-22 Ciba Geigy Ag Yeast as host for expression of heterologous glycosyl transferase enzymes
SE9201544L (sv) * 1991-05-31 1992-12-01 Ciba Geigy Ag Saett att framstaella glykosyltransferaser
JPH0823995A (ja) * 1994-07-14 1996-01-30 Green Cross Corp:The 宿主細胞由来のプロテアーゼで低分子化され得る蛋白質の製造方法
US20030113271A1 (en) * 1997-01-29 2003-06-19 University Technology Corporation Formulations for pulmonary delivery
US6207442B1 (en) * 1997-10-16 2001-03-27 Zymogenetics, Inc. Plasmid construction by homologous recombination

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4245051A (en) * 1978-03-30 1981-01-13 Rockefeller University Human serum plasminogen activator
US4558010A (en) * 1980-04-03 1985-12-10 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator and method of making plasminogen activator protein therefrom
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
FI88932C (fi) * 1982-04-15 1993-07-26 Genentech Inc Framstaellning av funktionellt maenskligt urokinasprotein
AR241654A1 (es) * 1982-05-05 1992-10-30 Genentech Inc Procedimiento para producir activador de plasminogeno de tejido humano.
NZ207926A (en) * 1983-04-25 1988-04-29 Genentech Inc Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
US5010003A (en) * 1983-04-25 1991-04-23 Genentech, Inc. Use of yeast homologous signals to secrete heterologous proteins
EP0154272B1 (en) * 1984-02-27 1992-01-08 Green Cross Corporation Production of human urokinase
JPS60256385A (ja) * 1984-05-18 1985-12-18 イーライ・リリー・アンド・カンパニー 酵母においてヘテロローガスポリペプチドを効率よく発現するための方法、ベクターおよび形質転換体
JPS60248181A (ja) * 1984-05-23 1985-12-07 Shiseido Co Ltd 酵母発現ベクタ−
EP0174835A1 (en) * 1984-09-11 1986-03-19 The Upjohn Company Human tissue plasminogen activator and recombinant DNA compounds
WO1986004351A1 (en) * 1985-01-25 1986-07-31 Sagami Chemical Research Center Stabilized human prourokinase
US5219569A (en) * 1985-04-22 1993-06-15 Genentech, Inc. Protease resistant urokinase
FR2581652B1 (fr) * 1985-04-22 1989-12-22 Genentech Inc Nouveaux mutants de l'activateur tissulaire du plasminogene humain
FI100106B (fi) * 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
DE19736137C1 (de) * 1997-08-20 1998-10-01 Daimler Benz Ag Verfahren zum Starten eines Verbrennungsmotors

Also Published As

Publication number Publication date
NO179046B (no) 1996-04-15
FI98219C (fi) 1997-05-12
HU204557B (en) 1992-01-28
FI881713A0 (fi) 1988-04-13
MX168507B (es) 1993-05-27
EP0288435B1 (en) 1994-03-16
DE3888386T2 (de) 1994-07-14
NO179046C (no) 1996-07-24
JPS63296689A (ja) 1988-12-02
EP0288435A1 (en) 1988-10-26
CA1341306C (en) 2001-10-23
FI98219B (fi) 1997-01-31
IL86058A0 (en) 1988-09-30
NZ224243A (en) 1991-02-26
DK203588D0 (da) 1988-04-14
DD274053A5 (de) 1989-12-06
DE3888386D1 (de) 1994-04-21
PT87230B (pt) 1992-08-31
ATE102994T1 (de) 1994-04-15
ES2061719T3 (es) 1994-12-16
JP2894696B2 (ja) 1999-05-24
DK203588A (da) 1988-10-16
IL86058A (en) 1993-07-08
NO881615D0 (no) 1988-04-14
AU1462688A (en) 1988-10-20
AU604305B2 (en) 1990-12-13
MY103358A (en) 1993-06-30
NO881615L (no) 1988-10-17
US5175105A (en) 1992-12-29
HUT46360A (en) 1988-10-28
PT87230A (pt) 1988-05-01

Similar Documents

Publication Publication Date Title
IE862178L (en) Poly-kringle plasminogen activator
IL68366A (en) Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture
HUT58798A (en) Process for producing growth factor of parenchimic hepatic celles, the gen for coding this and transformants for producing this factor
NO853012L (no) Nye genetiske sekvenser, interfenonpeptider av type i uttrykt av disse og organismer som produserer dem.
FI881713A (fi) Menetelmä urokinaasityyppisen plasminogeenin aktivaattorin tuottamiseksi
DE3851035D1 (de) Interleukin-7.
NO910719D0 (no) Vektorer og forbindelser for ekspresjon av glykosyleringsmutanter av humant protein c.
PT86276A (en) Method for the production of hybrid proteins
EP0776972A4 (en) GENE ENCODING THE IgG-Fc-BINDING PROTEIN
FI933821A0 (fi) Foerfarande foer framstaellning av proteasinhibitorer
EP0165759A3 (en) Mammalian promotors useful in yeast expression
ES2013184A6 (es) Un procemiento para producir un activador de plasminogeno de tipo tejido (t-pa) mejorado.

Legal Events

Date Code Title Description
BB Publication of examined application
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

MM Patent lapsed

Owner name: NOVARTIS AG